About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in San Francisco | 47 Studies

Clinical Trials Brain CancerSan Francisco

Brain Cancer Clinical Trials in San Francisco

Find 47 clinical trials for brain cancer near San Francisco, California. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in San Francisco

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 47 trials

CompletedA Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent GlioblastomaThe primary objective of this study is to evaluate the safety, efficacy and clinical activity of Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in…NCT03150862·Tucson, Arizona and 21 others CompletedVEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideThis phase II trial is studying how well VEGF Trap works in treating patients with recurrent malignant or anaplastic gliomas that did not respond to temozolomide.NCT00369590·Los Angeles, California and 6 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossThis is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss.NCT06810544·Scottsdale, Arizona and 14 others

CompletedErlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaErlotinib and temsirolimus and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00112736·Los Angeles, California and 7 others

RecruitingThe RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaResection of glioblastoma in or near functional brain tissue is challenging because of the proximity of important structures to the tumor site.NCT06273176·San Francisco, California and 7 others

CompletedPazopanib in Treating Patients With Recurrent GlioblastomaThis phase II trial is studying the side effects and how well pazopanib works in treating patients with recurrent glioblastoma.NCT00459381·Los Angeles, California and 8 others

CompletedTemozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006024·Birmingham, Alabama and 234 others

RecruitingThe SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)A greater extent of resection of the contrast-enhancing (CE) tumor part has been associated with improved outcomes in high-grade glioma patients.NCT06118723·San Francisco, California and 7 others

CompletedConvection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive GlioblastomaThis is a single-arm, open-label, multicenter study in approximately 52 adults with primary (de novo) GB that has recurred or progressed (first or second recurrence, including…NCT02858895·San Francisco, California and 6 others

CompletedGP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive GliomaVaccines made from a person's tumor cells, such as gp96 heat shock protein-peptide complex, may help the body build an effective immune response to kill tumor cells.NCT00293423·San Francisco, California and 2 others

Active not recruitingA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study.NCT04762069·Little Rock, Arkansas and 47 others

CompletedRamucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeRATIONALE: Monoclonal antibodies, such as ramucirumab and anti-PDGFR alpha monoclonal antibody IMC-3G3 (Olaratumab), can block tumor growth in different ways.NCT00895180·Birmingham, Alabama and 10 others

CompletedIL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant GliomaThis Phase 1 study in patients with newly diagnosed malignant glioma is designed to determine the highest dose of IL13-PE38QQR that can be safely administered by Convection…NCT00089427·San Francisco, California and 5 others

CompletedPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaThis 2-arm, randomized, phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine that may act to promote…NCT01480479·Birmingham, Alabama and 222 others

CompletedClinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaThis is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC).NCT03739372·San Diego, California and 11 others

RecruitingThe RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (≥70 years) or those with limited functioning performance at…NCT06146725·San Francisco, California and 7 others

Active not recruitingStudy of DSP-0390 in Patients With Recurrent High-Grade GliomaThis is a study of DSP-0390 in patients with recurrent high grade glioma.NCT05023551·San Francisco, California and 8 others

TerminatedTumor Treating Fields With Chemoradiation in Newly Diagnosed GBMThe study is an open-label pilot study in newly diagnosed glioblastoma patients following surgery.NCT03705351·San Francisco, California and 1 other

Active not recruitingA Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsThis is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in…NCT04478279·San Francisco, California and 10 others

TerminatedA Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaThe objective of this study is to evaluate the response of subjects with recurrent glioblastoma to continuous therapy of PLX3397.NCT01349036·Los Angeles, California and 5 others

Page 1 of 3Next

Other Conditions in San Francisco

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia